Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10129877 | Respiratory Medicine | 2018 | 39 Pages |
Abstract
There is an urgent need for improved and reliable techniques for small airways assessment in order to detect early damage, disease progression and response to treatment. Evidence from randomized clinical trials supports the benefits of extrafine ICS/LABA formulations in COPD, real world studies are necessary to confirm this.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Pietro Pirina, Maria Pia Foschino Barbaro, Davide Paleari, Antonio Spanevello,